GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
NR6A1 | hg38_v1_chr9_-_124771304_124771337 | 0.51 | 8.0e-16 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr14_-_106507476 Show fit | 19.87 |
ENST00000390621.3
|
immunoglobulin heavy variable 1-45 |
|
chr14_-_105626066 Show fit | 18.76 |
ENST00000641978.1
ENST00000390543.3 |
immunoglobulin heavy constant gamma 4 (G4m marker) |
|
chr14_-_105771405 Show fit | 17.29 |
ENST00000641136.1
ENST00000390551.6 |
immunoglobulin heavy constant gamma 3 (G3m marker) |
|
chr21_-_10649835 Show fit | 12.97 |
ENST00000622028.1
|
immunoglobulin heavy variable 1/OR21-1 (non-functional) |
|
chr19_-_6720641 Show fit | 12.77 |
ENST00000245907.11
|
complement C3 |
|
chr14_-_106185387 Show fit | 12.43 |
ENST00000390605.2
|
immunoglobulin heavy variable 1-18 |
|
chr12_-_91180365 Show fit | 12.04 |
ENST00000547937.5
|
decorin |
|
chr14_-_106715166 Show fit | 10.58 |
ENST00000390633.2
|
immunoglobulin heavy variable 1-69 |
|
chr14_-_106762576 Show fit | 10.39 |
ENST00000624687.1
|
immunoglobulin heavy variable 1-69D |
|
chr14_-_106737547 Show fit | 10.13 |
ENST00000632209.1
|
immunoglobulin heavy variable 1-69-2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 107.8 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
4.9 | 19.5 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.2 | 19.3 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
1.1 | 16.8 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.0 | 12.9 | GO:0007283 | spermatogenesis(GO:0007283) male gamete generation(GO:0048232) |
0.1 | 12.7 | GO:0070268 | cornification(GO:0070268) |
0.9 | 12.0 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
2.3 | 11.5 | GO:1902847 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
0.6 | 11.5 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.4 | 11.1 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 108.9 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.2 | 26.7 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 23.6 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.1 | 12.7 | GO:0005882 | intermediate filament(GO:0005882) |
0.9 | 12.0 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
1.3 | 11.6 | GO:0001520 | outer dense fiber(GO:0001520) |
0.9 | 11.5 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.5 | 7.9 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.4 | 7.6 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.1 | 6.9 | GO:0035580 | specific granule lumen(GO:0035580) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 108.9 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 37.2 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.2 | 19.6 | GO:0005518 | collagen binding(GO:0005518) |
0.5 | 16.8 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.6 | 14.8 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 12.8 | GO:0005198 | structural molecule activity(GO:0005198) |
2.8 | 11.1 | GO:0061769 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
0.0 | 7.8 | GO:0003729 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.2 | 7.6 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 7.6 | GO:0003714 | transcription corepressor activity(GO:0003714) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 21.2 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.5 | 12.8 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 12.0 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 11.8 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 6.9 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 6.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 6.7 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 6.5 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 5.7 | PID PLK1 PATHWAY | PLK1 signaling events |
0.2 | 5.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 16.9 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.4 | 12.0 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 11.7 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 8.5 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.3 | 7.5 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 7.0 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 6.9 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.3 | 6.8 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.1 | 6.7 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 5.4 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |